Retina
Retina

Central serous choroidopathy

Definition:
Central serous choroidopathy is a disease involving fluid accumulation under the retina caused by leakage from the choroid (blood vessel layer under the retina).

Alternative Names:
Central serous retinopathy

Causes, incidence, and risk factors:

The cause of this condition is unknown. Most patients are young men with aggressive, "type A" personalities, but anyone can be affected.

Stress appears to be a risk factor. The condition can also occur as a complication of steroid drug use.

Symptoms:
  • A dim and blurred blind spot in the center of vision
  • Objects appearing smaller or further away with the affected eye
  • Distortion of straight lines with the affected eye
Signs and tests:

Your health care provider can usually diagnose central serous choroidopathy can with a dilated examination of the retina. Fluorescein angiography, a test that photographically images the retinal circulation after a dye has been injected into the bloodstream, will confirm the diagnosis.

Treatment:

Most cases clear up without treatment in 1 or 2 months. Patients with more severe leakage and more severe visual loss or longer persistence of disease may be helped by laser treatment to seal the leak.

Patients who are using steroid drugs (for example, to treat autoimmune diseases) should discontinue their use if medically feasible. Any change in steroid drug use in these conditions MUST be under the supervision of a physician.

Expectations (prognosis):

Most patients recover normal vision without treatment. Recurrences occur in about half of all patients and have a similarly good prognosis. Rarely, patients develop permanent scars that impair central vision.

Complications:

A small number of patients will have complications of laser treatment which impair central vision, which is why most patients will be allowed to recover without treatment.

Calling your health care provider:

If visual symptoms worsen.

Prevention:

There are no known preventive measures. Although there is a clear association with stress, there is no evidence that tranquilizer drugs have any benefit in preventing or treating central serous choroidopathy.


Review Date: 11/5/2002
Reviewed By: Raymond S. Douglas M.D., Ph.D. Department of Ophthalmology, UCLA Medical Center, Los Angeles, CA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.